Nivolumab yields long-term survival benefit in advanced NSCLCAugust 26, 2019Lung CancerImmuno-oncology
EHR-derived data on tumor progression may predict survivalAugust 19, 2019Lung CancerPractice Management
Rozlytrek approved for ROS1-positive metastatic NSCLC, cancers with NTRK gene fusion defectsAugust 15, 2019Lung CancerSarcoma & GIST
Center’s experience casts doubt on clinical utility of NGSAugust 13, 2019Lung CancerPatient & Survivor Care
Immune-related toxicities, hospitalization common with checkpoint inhibitor therapyAugust 12, 2019Lung CancerImmuno-oncologyHead & Neck/Thyroid Cancers
COPD adds complexity to shared decision making for LDCT lung cancer screeningAugust 5, 2019Lung CancerPreventive Care
Study outlines survival factors with nivolumabJuly 25, 2019Lung CancerRenal Cell CarcinomaMelanomaImmuno-oncology
